Search for Andrew Witty and
  1. September 19, 2014

    GSK to pay £297m fine for Chinese bribes

    GlaxoSmithKline will pay a £297m fine after being found guilty of bribery by a Chinese court – the biggest such penalty...

  2. July 31, 2014

    Drug pricing: Bitter pill

    When delegates turned up for a big healthcare conference at New York’s plush Waldorf Astoria hotel in February, they were...

  1. July 28, 2014

    GSK and Reckitt: pharming out

    Well done Reckitt Benckiser and GlaxoSmithKline. But what took you so long? Both have recognised that pharmaceuticals and...

  2. July 27, 2014

    GSK’s Witty fights back amid bribery scandal and profit warning

    For most of his six years as chief executive of GlaxoSmithKline, Andrew Witty has been the golden boy of British business....

  3. July 27, 2014

    GSK opens issue of spinning off consumer division

    GlaxoSmithKline’s chief executive has opened the possibility of the group being broken up in the future as he pushes through...

  4. July 24, 2014

    GSK investigating Syrian charges

    GlaxoSmithKline is investigating fresh allegations of corruption, this time in Syria, adding to a series of bribery claims...

  5. July 23, 2014

    Longtime GSK favourite stumbles in the final furlong

    The Queen’s horse Estimate, former Gold Cup champion, has failed a drug test, as has GlaxoSmithKline. On Wednesday the group...

  6. July 23, 2014

    GSK cuts guidance as sales and profits slide

    Shares in GlaxoSmithKline fell almost 5 per cent on Wednesday after a profit warning highlighted the UK pharmaceuticals...

  7. June 4, 2014

    GSK pays settlements to 40-plus US states

    GlaxoSmithKline has agreed to pay $105m to more than 40 US states to settle allegations of unlawful marketing, ending a long...

  8. May 29, 2014

    GlaxoSmithKline asks for bids on older drugs list

    GlaxoSmithKline has invited private equity firms to bid for some of its older drugs in the latest step by Sir Andrew Witty,...

  9. April 30, 2014

    GSK plays down prospect of white knight bid for AstraZeneca

    The chief executive of GlaxoSmithKline all but ruled out a white knight bid by the UK pharmaceuticals company for...

  10. April 22, 2014

    Deals fever grips pharmaceuticals industry

    A near $50bn takeover battle for the maker of Botox and a multibillion-dollar asset swap between Novartis and...

  11. April 22, 2014

    Sir Andrew Witty seeks to overcome most difficult year at GSK

    For Sir Andrew Witty, the past year has been the most difficult of his six years as chief executive of GlaxoSmithKline....

  12. April 22, 2014

    GSK chief quick to distance Novartis deal from megamerger mania

    Another day, another big pharma deal. Novartis and GlaxoSmithKline became the latest companies to join the industry’s...

  13. April 22, 2014

    The Joker’s on Quindell

    Holy mackerel, Batman! A shortseller called Gotham City Research has triggered a 40 per cent plunge in the shares of...

  14. April 22, 2014

    Novartis buys GSK business for up to $16bn in restructuring

    Novartis and GlaxoSmithKline have agreed to swap a series of assets in a multibillion-dollar deal that will reshape two of...

  15. April 7, 2014

    Reform of pharma practices should go wider than GSK

    Two cases do not make an epidemic. But it is still serious for GlaxoSmithKline that allegations of bribery have surfaced in...

  16. April 1, 2014

    Drugmakers learn to blend commerce with philanthropy in Africa

    Africa has rarely been a source of good publicity for big pharma. But two events this week suggest the drugs industry is...

  17. February 5, 2014

    GlaxoSmithKline sticks with bet on emerging markets

    GlaxoSmithKline, the UK drugmaker, will press ahead with its big bet on emerging markets, despite turmoil in its scandal-hit...

  18. December 17, 2013

    GSK China probe flags up wider concerns

    Unshaven and dressed in a blue and grey striped T-shirt, Liang Hong looked nondescript on screen. But his words, broadcast...

  19. December 16, 2013

    GSK scraps sales rep targets after scandal

    GlaxoSmithKline is to scrap individual sales targets for its commercial staff as it seeks to repair its image and reform...

  20. December 3, 2013

    Detained couple’s son in call to GSK boss

    The son of a British fraud investigator detained in Shanghai has called on the head of GlaxoSmithKline, the UK drugs company...

  21. December 3, 2013

    David Cameron defends GSK during China trip

    David Cameron has risked angering the Chinese government by launching a robust defence of GlaxoSmithKline as the UK drug...

  22. December 2, 2013

    Spotlight on Cameron’s China delegation

    David Cameron has taken a business delegation of 127 executives with him to China, most of whom will have very little...

  23. November 24, 2013

    SMEs and business schools need closer working links

     Lord Digby Jones – the former head of the CBI, the employers’ body – once said that when it comes to business schools,...

  24. October 23, 2013

    GSK China sales plummet 60% since scandal

    GlaxoSmithKline’s medicine and vaccine sales in China have dropped 61 per cent since the summer, following a high-profile...

  25. October 15, 2013

    Ministers urged to tap university research

    A leading industrialist has urged ministers to commit at least £1bn in the next parliament to university-led projects that...

  26. September 23, 2013

    GlaxoSmithKline China sales face growing pressure

    Sales of GlaxoSmithKline’s medicines in China are thought to have dropped 30 per cent since officials accused the UK...

  27. July 24, 2013

    GSK: in need of a Chinese remedy

    Scandals are, by nature, vague and confusing things. Are things as bad as they look? How long until the fog clears? Since...

  28. July 24, 2013

    Bribery built into the fabric of Chinese healthcare system

    In a hospital on the outskirts of Beijing, the hallway outside the main nurses’ station was unusually empty on Wednesday....

  29. July 24, 2013

    UK call to step up east-west fight against crime

    Britain has called on China to accelerate plans to share information in criminal investigations in a sign of a growing drive...

  30. July 22, 2013

    GSK’s mea kinda culpa is a first step to redemption

    GlaxoSmithKline is wise to admit that staff may have broken Chinese bribery laws. When big companies stonewall during a...

  31. MBA blog

    July 22, 2013

    Inspiration from an entrepreneur

    In late spring we were fortunate to attend the third and final lecture in the Pears Business School Lecture Series. The...

  32. July 15, 2013

    GSK probe shows the peril of operating in corrupt markets

    Old Asia hands doubt that police action against executives of GlaxoSmithKline in China marks the dawning of a new era of...

  33. July 15, 2013

    GSK is test case in China’s rules laboratory

    Hundreds of millions of dollars of allegedly improper payments under review by the Chinese police. Evidence of sexual...

  34. July 4, 2013

    Pharma price wars patently transcend all ideologies

    Police in Changsha, China, have accused GlaxoSmithKline staff of “economic crimes”. The charge sounds distinctly Maoist, as...

  35. April 24, 2013

    GSK to sell off Lucozade and Ribena

    GlaxoSmithKline is to sell off its Lucozade and Ribena drinks business by the end of this year and place its off-patent...

  36. April 8, 2013

    Growth prospects seen in university research

    Sir Andrew Witty is to come up with a plan on how British universities might go about engaging more with local businesses in...

  37. March 10, 2013

    CEOs applaud protection of overseas aid

    David Cameron’s decision to protect Britain’s overseas aid budget has been praised by Britain’s leading business figures,...

  38. February 6, 2013

    GSK unveils European restructuring plans

    GlaxoSmithKline said it was considering the sale of its Ribena and Lucozade drinks brands to refocus on faster-growing...

Search for Andrew Witty and